Optimizing Reimbursement for Routinely Recommended Maternal Immunizations
Coding Tips for Obstetricians
Published March 2026
Immunizations are recommended as part of comprehensive care for pregnant people. Obstetrician–gynecologists have a unique opportunity to reduce the frequency of vaccine-preventable diseases with
- awareness of current vaccine recommendations
- education and encouragement of their patients to receive appropriate vaccines
- integration of vaccination into routine clinical practice
ACOG encourages clinicians to stock and, ideally, administer all recommended vaccines in their offices. Studies show that immunization rates are higher when a trusted clinician can strongly recommend, offer, and administer the vaccine during the same visit, rather than recommending vaccination and referring the patient elsewhere for vaccination.
Influenza and Tdap vaccines are routinely offered and administered by a majority of prenatal care practices, while other important vaccines are not as commonly stocked, leaving significant gaps in care. With proper documentation and coding, billing for both counseling about and administration of vaccines can be reported to third-party payers, and reimbursement can be received. In general, the appropriate vaccine product code, which is also specific to different manufacturers’ brands within a class of vaccines, should always be reported along with the appropriate Current Procedural Terminology (CPT) vaccine administration code for the vaccination procedure itself.
Coding Tips
- Must include relevant ICD-10-CM codes indicating a vaccine was administered during a pregnancy visit, Z23 (vaccine encounter).
- Document the gestational age at the time of vaccination using the correct ICD-10-CM diagnosis codes (Z3A.X, X = gestational age in weeks).
- Use the appropriate administration codes:
- 90471 (for one vaccine in patients over age 18)
- AND 90472 (for each additional vaccine given after the first one in the same visit in patients over age 18)
—OR—
- 90460 (for patients through 18 years of age or younger when vaccine counseling is provided)
- AND 90461 (for each additional vaccine given after the first one in the same visit in patients in patients through age 18 or younger)
- Some payers may require modifier “-33” on the administration code to indicate the service was preventive and exempt from patient cost-sharing. Check payer coding guidelines.
- If distinct vaccine counseling beyond the standard administration is documented, an Evaluation and Management (E/M) visit code may also be billed.
Reimbursement for Vaccinations – Coding Formula
A vaccination procedure has two components: 1) the administration of the vaccine and 2) the vaccine product (drug) itself. The administration may be performed by the obstetrician–gynecologist or other health care professional. When the vaccine drug and the administration are provided by the physician’s office, report a code for the vaccine and a code for the administration of the vaccine.
- Formula: ICD-10-CM Code + Administration CPT Code + Vaccine-Specific CPT Code (different for each vaccine)
- Z23 – Encounter for immunization (any) + 90480 + Vaccine-Specific CPT Code (See table below)
- Z23 – Encounter for immunization (any) + 90460, 90461, 90471, 90472 + Vaccine-Specific CPT Code (See table below)
Table: Vaccines Commonly Administered to Pregnant Patients
| Vaccine | Vaccine Description | Code for Vaccine Product (CPT Code) | Administration CPT Code |
|---|---|---|---|
| COVID-19 | COVID-19 vaccine, tris-sucrose, 30 micrograms, for IM use | 91320 | 90480 |
| COVID-19 vaccine, spike, 50 micrograms/0.5 mL, for IM use | 91322 | ||
| COVID-19 vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 micrograms/0.5 mL dosage, for intramuscular use | 91304 | ||
| Influenza | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 90656 | 90460–90472 |
| Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 90673 | ||
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 90658 | ||
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 90661 | ||
| RSV | Respiratory syncytial virus vaccine, preF, subunit, bivalent, for intramuscular use | 90678 | 90460–90472 |
| Tdap | Tetanus, diphtheria toxoids, and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 90715 | 90460–90472 |
Coding Scenarios
- A 34-week pregnant woman is given the maternal RSV vaccine (Abrysvo). Which of the following are the correct ICD-10-CM codes for a routine prenatal visit with the administration of the RSV vaccine?
- Z34.83, Z3A.34
- Z34.32, Z24
- Z34.92, Z3A.32
- Z23, Z3A.34
-
D. Z23, Z3A.34
-
Z23 is used to indicate an encounter for immunization, making it appropriate for documenting the administration of the RSV vaccine during a routine prenatal visit. Z3A.34 is used to indicate the fetus’s gestation in weeks. These codes are specifically for use on the mother’s record.
- A 30-year-old pregnant woman presents at 32 weeks of gestation to the clinic for the administration of the maternal RSV vaccine (Abrysvo). Which of the following are the correct CPT codes for the vaccine code and the administration of the vaccine?
- 96372, 90683
- 90460, 90679
- 90471, 90678
- 96380, 90381
-
C. 90471, 90678
-
The CPT code 90471 is used for the administration of a vaccine when no other significant, separately identifiable E/M service is provided. It covers the administration of the RSV vaccine. The CPT code 90678 covers the RSV vaccine product itself.
- A 25-year-old patient who is nulligravid presents for a routine prenatal care visit at 12 weeks of gestation. During this visit, the patient receives an influenza vaccination. Assuming the patient has a commercial payer, what is the appropriate set of CPT and ICD-10-CM codes to report the immunization administration and the encounter? Select all that apply.
- Z34.01, Z23, 90471, 90656
- Z3A.12, Z23, 90471, 90686
- Z23, 90472, 90686
- Z34.01, 90460, 90656
-
A. Z34.01, Z23, 90471, 90656; and B. Z3A.12, 90471, 90686
-
Pregnant patients will request, and in some instances require, vaccinations during their pregnancies. Vaccination services performed during pregnancy should be billed separately at the time of the service. If a patient has any additional conditions that might put her at high risk of influenza, report a secondary code for the high-risk condition. This process will facilitate payment from plans that only cover vaccinations for patients identified as high-risk patients. A separate E/M service should not be reported because the office visit is part of the global obstetric package. The ICD-10-CM linkages and appropriate procedure codes are listed as follows:
- Z23 Encounter for immunization
- Z34.01 Encounter for supervision of normal first pregnancy, first trimester
- Z3A.12 12 weeks of gestation (optional)
- 90656 Preservative-free influenza vaccine (trivalent) (drug), for intramuscular use
OR
- 90686 Influenza vaccine (quadrivalent), for intramuscular use OR
- 90658 Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use
- 90471 Vaccine administration
- The patient from the previous scenario comes in for a routine prenatal appointment at 28 weeks of gestation. She is Rh-negative and is given antenatal Rho(D) immune globulin. She also receives her Tdap vaccination. Which of the following represents the most appropriate set of ICD-10-CM and CPT codes to report the Rho(D) immune globulin and the Tdap immunization (assuming commercial payer rules for coding)? Select all that apply.
- Z29.13, Z3A.28, 96372, 90384
- Z3A.12, 90460, 90715, 90384
- Z29.13, Z23, 96375, 90384
- Z34.03, Z23, Z3A.28, 90471, 90715
-
A. Z29.13, Z3A.28, 96372, 90384 and D. Z34.03, Z23, Z3A.28, 90471, 90715
-
It is appropriate to code and bill for the Rho(D) immune globulin administration outside of the global obstetric package. Some payers may require the use of special HCPCS codes (“J” codes) to identify the Rho(D) immune globulin product. Also, note that the CPT codes for administration of Rho(D) immune globulin are different than those used for administration of vaccines. The ICD-10-CM linkages and appropriate procedure codes are listed as follows:
- Z23 Encounter for immunization
- Z29.11 Encounter for prophylactic Rho(D) immune globulin
- Z34.03 Encounter for supervision of normal first pregnancy, third trimester
- Z3A.28 28 weeks of gestation (optional)
- 90384 Rho(D) immune globulin (RhIg), full dose (drug), for intramuscular use
OR
- J2790 Injection, Rho(D) immune globulin, human, full dose, 300 micrograms (1,500 international units)
- 96372 Injection (therapeutic, prophylactic, or diagnostic), for subcutaneous or intramuscular use
- 90715 Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use
- 90471 Vaccine administration
Ask Questions, Get Answers
The ACOG Payment Advocacy and Policy Portal is free to ACOG members and their staff.
Go© 2026 American College of Obstetricians & Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the internet, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher. Any use of this publication to train generative artificial intelligence (AI) technologies, or as part of a generative AI language model (LLM) to generate text or responses to prompts, is expressly prohibited. Unauthorized use of this publication for AI training or development is strictly prohibited. The College reserves all rights to license uses of this work for generative AI training and development or as part of an LLM platform